Company profile
Aspira Women's Health Inc. CIK 926617
Ticker
AWHL (OTC)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Austin, TX 78738
Fiscal year end
2025 (FY)
Key Financials
Revenue
$343.0K
Net income
-$12.78M
Total assets
$5.46M
Total liabilities
$12.39M
Stockholders' equity
-$6.93M
Cash & equivalents
$1.76M
Operating income
-$7.91M
Operating cash flow
-$7.03M
Capital expenditures
$16.0K
Fiscal year 2025, via 10-K filed 2026-04-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-2,307.0%
Net margin
-3,725.9%
Free cash flow
-$7.05M
Free cash flow margin
-2,053.9%
Liabilities / assets
227.1%
Equity / assets
-127.1%
CapEx / revenue
4.7%
Operating cash flow / net income
0.55×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$343.0K
-$12.78M
$5.46M
$12.39M
-$6.93M
2024
$4.0K
-$13.09M
$5.49M
$8.05M
-$2.56M
2023
$87.00M
-$16.69M
$6.26M
$8.63M
-$2.37M
2022
$8.18M
-$29.89M
$17.37M
$10.39M
$6.98M
2021
$6.81M
-$31.66M
$41.08M
$10.91M
$30.17M
Company Details
SIC code
2835
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-04-01
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Austin, TX 78738
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.